Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||
| Cash from operating activities | -40.39%147.52M | 38.60%247.48M | 264.91%178.56M | 48.93M |
| Net profit before non-cash adjustment | 21.47%232.77M | 79.26%191.63M | -8.39%106.9M | --116.69M |
| Total adjustment of non-cash items | -146.96%-16.85M | 348.31%35.88M | 81.39%-14.45M | ---77.65M |
| -Depreciation and amortization | -28.35%9.44M | 13.97%13.17M | 0.93%11.55M | --11.45M |
| -Reversal of impairment losses recognized in profit and loss | ---- | --0 | --2.81M | --0 |
| -Share of associates | -3,831.93%-12.39M | 119.40%332K | 5.78%-1.71M | ---1.82M |
| -Disposal profit | 282.82%5.69M | 78.37%-3.11M | -51.46%-14.4M | ---9.5M |
| -Net exchange gains and losses | 102.13%514K | -21.95%-24.14M | 22.16%-19.79M | ---25.43M |
| -Other non-cash items | -140.50%-20.1M | 600.32%49.63M | 113.54%7.09M | ---52.35M |
| Changes in working capital | -442.50%-68.41M | -76.80%19.97M | 770.66%86.1M | --9.89M |
| -Change in receivables | -660.58%-63.59M | 224.94%11.34M | -29.39%-9.08M | ---7.02M |
| -Change in inventory | -1,221.97%-4.15M | 90.65%-314K | -287.64%-3.36M | ---866K |
| -Change in payables | 6,901.16%12.04M | -93.88%172K | 111.26%2.81M | ---24.96M |
| -Provision for loans, leases and other losses | -135.15%-1.77M | -110.72%-751K | 1,744.21%7.01M | --380K |
| -Changes in other current assets | -214.96%-10.95M | -89.26%9.52M | 109.50%88.72M | --42.35M |
| Dividends paid (cash flow from operating activities) | ||||
| Dividends received (cash flow from operating activities) | ||||
| Interest paid (cash flow from operating activities) | 33.04%-75K | -314.81%-112K | 53.45%-27K | -58K |
| Interest received (cash flow from operating activities) | 18,167.44%7.86M | 53.57%43K | -54.84%28K | 62K |
| Tax refund paid | -145.91%-53.08M | 70.24%-21.59M | -672.70%-72.54M | -9.39M |
| Other operating cash inflow (outflow) | 0 | 200.00%2K | -100.01%-2K | 25.28M |
| Operating cash flow | -54.74%102.22M | 113.02%225.83M | 63.53%106.01M | --64.83M |
| Investing cash flow | ||||
| Net PPE purchase and sale | --0 | ---902K | --0 | --1.22M |
| Net intangibles purchase and sale | 70.99%-600K | 87.93%-2.07M | -193.17%-17.14M | ---5.85M |
| Net business purchase and sale | ---70M | --0 | --8.87M | --0 |
| Net investment product transactions | -0.81%-23.01M | 2.55%-22.82M | -18.56%-23.42M | ---19.76M |
| Dividends received (cash flow from investment activities) | 366.42%4.33M | -93.51%929K | 188.79%14.32M | --4.96M |
| Net changes in other investments | 99.12%-3K | 36.16%-339K | -190.61%-531K | --586K |
| Investing cash flow | -267.38%-89.28M | -35.80%-24.3M | 4.97%-17.9M | ---18.83M |
| Financing cash flow | ||||
| Net common stock issuance | -69.04%72.77M | --235.06M | --0 | ---- |
| Increase or decrease of lease financing | 18.62%-647K | -0.89%-795K | -4.10%-788K | ---757K |
| Issuance fees | -302.60%-8.05M | ---2M | --0 | ---- |
| Cash dividends for minorities | 97.92%-490K | ---23.53M | --0 | ---- |
| Net other fund-raising expenses | ---1K | ---- | ---- | ---- |
| Financing cash flow | -69.54%63.58M | 26,589.72%208.74M | -4.10%-788K | ---757K |
| Net cash flow | ||||
| Beginning cash position | 50.46%1.32B | 16.22%880.09M | 11.81%757.25M | --677.27M |
| Current changes in cash | -81.35%76.52M | 369.79%410.27M | 93.05%87.33M | --45.24M |
| Effect of exchange rate changes | -104.55%-1.54M | -4.74%33.83M | 2.23%35.51M | --34.73M |
| Cash adjustments other than cash changes | ---- | 200.00%1K | -200.00%-1K | --1K |
| End cash Position | 5.66%1.4B | 50.46%1.32B | 16.22%880.09M | --757.25M |
| Free cash flow | -54.59%101.62M | 151.76%223.76M | 50.69%88.88M | --58.98M |
| Currency Unit | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |